Entheon Biomedical Statistics

Total Valuation

Entheon Biomedical has a market cap or net worth of CAD 1.20 million. The enterprise value is 967,355.

Market Cap	1.20M
Enterprise Value	967,355

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Entheon Biomedical has 8.86 million shares outstanding. The number of shares has increased by 18.52% in one year.

Current Share Class	n/a
Shares Outstanding	8.86M
Shares Change (YoY)	+18.52%
Shares Change (QoQ)	+21.03%
Owned by Insiders (%)	3.27%
Owned by Institutions (%)	n/a
Float	8.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	5.22
P/TBV Ratio	5.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.14
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.10

Current Ratio	12.10
Quick Ratio	11.52
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -99.51% and return on invested capital (ROIC) is -65.35%.

Return on Equity (ROE)	-99.51%
Return on Assets (ROA)	-59.41%
Return on Capital (ROIC)	-65.35%
Revenue Per Employee	n/a
Profits Per Employee	-307,687
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +170.00% in the last 52 weeks. The beta is 1.05, so Entheon Biomedical's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	+170.00%
50-Day Moving Average	0.12
200-Day Moving Average	0.13
Relative Strength Index (RSI)	55.82
Average Volume (20 Days)	6,922

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-323,302
Pretax Income	-307,687
Net Income	-307,687
EBITDA	n/a
EBIT	-323,302
Earnings Per Share (EPS)	-0.04

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	228,599
Total Debt	n/a
Net Cash	228,599
Net Cash Per Share	0.03
Equity (Book Value)	229,128
Book Value Per Share	0.03
Working Capital	224,128

Full Balance Sheet

Cash Flow

Operating Cash Flow	-310,106
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Entheon Biomedical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.52%
Shareholder Yield	-18.52%
Earnings Yield	-32.54%
FCF Yield	n/a

Stock Splits

The last stock split was on March 1, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	Mar 1, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

Entheon Biomedical has an Altman Z-Score of -96.98. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-96.98
Piotroski F-Score	n/a